Squadron Capital Management Llc Portfolio Stock Holdings
Squadron Capital Management Llc disclosed 30 stock positions valued at approximately $250.0 million in its latest SEC 13F filing. The largest holdings include RELMADA THERAPEUTICS INC, COGENT BIOSCIENCES INC, and KALVISTA PHARMACEUTICALS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 30
- Portfolio Value
- $250.0M
Holdings by Sector
Squadron Capital Management Llc Portfolio Holdings in Q1 2026
16 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 23.60% | 8,474,571 | +1,774,571 | +26.49% | $58,983,014 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 12.13% | 787,492 | +7,492 | +0.96% | $30,310,567 |
| KALVISTA PHARMACEUTICALS INC | KALV | Healthcare | 7.93% | 985,100 | +285,100 | +40.73% | $19,830,063 |
| KODIAK SCIENCES INC | KOD | Healthcare | 5.80% | 380,000 | +88,290 | +30.27% | $14,485,600 |
| ABIVAX SA | ABVX | Healthcare | 5.79% | 130,000 | -15,000 | -10.34% | $14,475,500 |
| EDGEWISE THERAPEUTICS INC | EWTX | Healthcare | 4.41% | 350,000 | - | - | $11,025,000 |
| ZENTALIS PHARMACEUTICALS INC | ZNTL | Healthcare | 3.40% | 3,631,000 | +3,631,000 | +100.00% | $8,496,540 |
| SCYNEXIS INC | SCYX | Healthcare | 2.79% | 7,608,695 | +7,608,695 | +100.00% | $6,976,412 |
| RELAY THERAPEUTICS INC | RLAY | Healthcare | 2.68% | 672,500 | +672,500 | +100.00% | $6,691,375 |
| C4 THERAPEUTICS INC | CCCC | Healthcare | 2.37% | 2,250,000 | +2,250,000 | +100.00% | $5,917,500 |
| INHIBIKASE THERAPEUTICS INC | IKT | Healthcare | 2.35% | 3,500,000 | -725,000 | -17.16% | $5,880,000 |
| LIPOCINE INC NEW | LPCN | Healthcare | 1.44% | 450,000 | -80,000 | -15.09% | $3,595,500 |
| ALX ONCOLOGY HLDGS INC | ALXO | Healthcare | 1.17% | 1,460,000 | +1,460,000 | +100.00% | $2,927,300 |
| CONTEXT THERAPEUTICS INC | CNTX | Healthcare | 1.15% | 1,100,000 | +1,100,000 | +100.00% | $2,882,000 |
| THERAPEUTICSMD INC | TXMD | Healthcare | 0.34% | 420,421 | +420,421 | +100.00% | $849,250 |
| WEREWOLF THERAPEUTICS INC | HOWL | Healthcare | 0.19% | 563,535 | +563,535 | +100.00% | $469,199 |
Squadron Capital Management Llc Options Holdings in Q1 2026
6 options positions in the latest reporting period.
Page 1 of 1
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q1 2026 | KALV | KalVista Pharmaceuticals, Inc. | CALL | 315,000 | $6,340,950 |
| Q1 2026 | IDYA | IDEAYA Biosciences, Inc. | PUT | 120,000 | $3,998,400 |
| Q1 2026 | IDYA | IDEAYA Biosciences, Inc. | CALL | 104,300 | $3,475,276 |
| Q1 2026 | AVBP | ArriVent BioPharma, Inc. | CALL | 110,000 | $2,537,700 |
| Q1 2026 | RLAY | Relay Therapeutics, Inc. | CALL | 150,000 | $1,492,500 |
| Q1 2026 | ZNTL | Zentalis Pharmaceuticals, Inc. | CALL | 400,000 | $936,000 |
Notional value represents the total exposure of the options position.